These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9295972)

  • 21. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
    Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
    Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
    Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The expression of C-myc, N-ras mRNA and its relations to the differentiation of preneoplastic altered hepatocytes].
    Lin YZ
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):97-100. PubMed ID: 8223133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks.
    Möröy T; Marchio A; Etiemble J; Trépo C; Tiollais P; Buendia MA
    Nature; 1986 Nov 20-26; 324(6094):276-9. PubMed ID: 3024010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat.
    Nakaji M; Yano Y; Ninomiya T; Seo Y; Hamano K; Yoon S; Kasuga M; Teramoto T; Hayashi Y; Yokozaki H
    Carcinogenesis; 2004 Mar; 25(3):389-97. PubMed ID: 14633663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The win locus involved in activation of the distal N-myc2 gene upon WHV integration in woodchuck liver tumors harbors S/MAR elements.
    Bruni R; D'Ugo E; Villano U; Fourel G; Buendia MA; Rapicetta M
    Virology; 2004 Nov; 329(1):1-10. PubMed ID: 15476869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of the protein kinase C-alpha gene overexpression in rat preneoplastic liver by selenium].
    Chen HC
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):279-81. PubMed ID: 7909746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
    Ghebranious N; Sell S
    Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
    Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
    Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
    Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
    J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic mice.
    Yamazaki K; Suzuki K; Ohkoshi S; Yano M; Kurita S; Aoki YH; Toba K; Takamura MA; Yamagiwa S; Matsuda Y; Aoyagi Y
    J Hepatol; 2008 Feb; 48(2):255-65. PubMed ID: 18083266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.